acrystal's library 55 articles Export

	Introduction: the history of arsenic trioxide in cancer therapy. [My Copy] The oncologist, Vol. 6 Suppl 2 (2001), pp. 1-2. by K. H. Antman posted to no-tag by acrystal on 2009-03-03 13:22:24 as
	Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. [My Copy] Nature, Vol. 243, No. 5405. (1 June 1973), pp. 290-293. by J. D. Rowley posted to no-tag by acrystal on 2009-03-03 13:21:49 as along with 1 person catcremona
	Chronic myeloid leukemia--advances in biology and new approaches to treatment. [My Copy] The New England journal of medicine, Vol. 349, No. 15. (9 October 2003), pp. 1451-1464. by J. M. Goldman, J. V. Melo posted to no-tag by acrystal on 2009-03-03 13:21:06 as along with 1 person absterga
	Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. [My Copy] The New England journal of medicine, Vol. 348, No. 11. (13 March 2003), pp. 994-1004. by S. G. O'Brien, F. Guilhot, R. A. Larson, et al.I. Gathmann, M. Baccarani, F. Cervantes, J. J. Cornelissen, T. Fischer, A. Hochhaus, T. Hughes, K. Lechner, J. L. Nielsen, P. Rousselot, J. Reiffers, G. Saglio, J. Shepherd, B. Simonsson, A. Gratwohl, J. M. Goldman, H. Kantarjian, K. Taylor, G. Verhoef, A. E. Bolton, R. Capdeville, B. J. Druker, posted to no-tag by acrystal on 2009-03-03 13:20:11 as
	Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [My Copy] The New England journal of medicine, Vol. 344, No. 14. (5 April 2001), pp. 1084-1086. by J. M. Goldman, J. V. Melo posted to no-tag by acrystal on 2009-03-03 13:19:26 as
	Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [My Copy] The New England journal of medicine, Vol. 344, No. 14. (5 April 2001), pp. 1031-1037. by B. J. Druker, M. Talpaz, D. J. Resta, et al.B. Peng, E. Buchdunger, J. M. Ford, N. B. Lydon, H. Kantarjian, R. Capdeville, S. Ohno-Jones, C. L. Sawyers posted to no-tag by acrystal on 2009-03-03 13:18:37 as
	Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia [My Copy] N Engl J Med, Vol. 355, No. 23. (7 December 2006), pp. 2408-2417. by Brian J. Druker, Francois Guilhot, Stephen G. O'Brien, et al.Insa Gathmann, Hagop Kantarjian, Norbert Gattermann, Michael W. N. Deininger, Richard T. Silver, John M. Goldman, Richard M. Stone, Francisco Cervantes, Andreas Hochhaus, Bayard L. Powell, Janice L. Gabrilove, Philippe Rousselot, Josy Reiffers, Jan J. Cornelissen, Timothy Hughes, Hermine Agis, Thomas Fischer, Gregor Verhoef, John Shepherd, Giuseppe Saglio, Alois Gratwohl, Johan L. Nielsen, Jerald P. Radich, Bengt Simonsson, Kerry Taylor, Michele Baccarani, Charlene So, Laurie Letvak, Richard A. Larson, the IRIS Investigators posted to no-tag by acrystal on 2009-03-03 13:17:53 as along with 3 people saradtc waghsk Amazoness
	Flying under the radar: the new wave of BCR–ABL inhibitors [My Copy] Nature Reviews Drug Discovery, Vol. 6, No. 10., pp. 834-848. by Alfonso Quintás-Cardama, Hagop Kantarjian, Jorge Cortes posted to no-tag by acrystal on 2009-03-03 13:17:15 as
	Imatinib. [My Copy] The oncologist, Vol. 12, No. 12. (December 2007), pp. 1390-1394. by C. E. de Kogel, J. H. Schellens posted to no-tag by acrystal on 2009-03-03 13:16:40 as along with 1 person ajaymalik
	Activation of tyrosine kinases by mutation of the gatekeeper threonine [My Copy] Nature Structural & Molecular Biology, Vol. 15, No. 10. (14 September 2008), pp. 1109-1118. by Mohammad Azam, Markus A. Seeliger, Nathanael S. Gray, John Kuriyan, George Q. Daley posted to no-tag by acrystal on 2009-03-03 13:13:45 as along with 3 people csjonline renatomilani sschurer
	Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome [My Copy] Science, Vol. 247, No. 4944. (16 February 1990), pp. 824-830. by G. Q. Daley, R. A. Van Etten, D. Baltimore posted to no-tag by acrystal on 2009-03-03 13:13:01 as
	Circumventing resistance to kinase-inhibitor therapy. [My Copy] The New England journal of medicine, Vol. 354, No. 24. (15 June 2006), pp. 2594-2596. by B. J. Druker posted to no-tag by acrystal on 2009-03-03 13:12:02 as
	Treatment for chronic myelogenous leukemia: the long road to imatinib. [My Copy] The Journal of clinical investigation, Vol. 117, No. 8. (August 2007), pp. 2036-2043. by T. Hunter posted to no-tag by acrystal on 2009-03-03 13:07:29 as
	Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia. [My Copy] Blood, Vol. 110, No. 7. (1 October 2007), pp. 2242-2249. by T. O'Hare, C. A. Eide, M. W. Deininger posted to no-tag by acrystal on 2009-03-03 13:06:43 as
	Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias. [My Copy] Oncogene, Vol. 22, No. 47. (20 October 2003), pp. 7389-7395. by N. P. Shah, C. L. Sawyers posted to no-tag by acrystal on 2009-03-03 13:05:39 as
	Imatinib resistance in CML. [My Copy] Cancer letters, Vol. 274, No. 1. (8 February 2009), pp. 1-9. by G. Volpe, C. Panuzzo, S. Ulisciani, D. Cilloni posted to no-tag by acrystal on 2009-03-03 13:04:44 as
	BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia. [My Copy] Oncogene, Vol. 21, No. 56. (9 December 2002), pp. 8547-8559. by S. Salesse, C. M. Verfaillie posted to no-tag by acrystal on 2009-03-03 13:03:55 as
	Acute leukaemia in bcr/abl transgenic mice. [My Copy] Nature, Vol. 344, No. 6263. (15 March 1990), pp. 251-253. by N. Heisterkamp, G. Jenster, J. ten Hoeve, D. Zovich, P. K. Pattengale, J. Groffen posted to no-tag by acrystal on 2009-03-03 13:03:18 as
	STI571: targeting BCR-ABL as therapy for CML. [My Copy] The oncologist, Vol. 6, No. 3. (2001), pp. 233-238. by M. J. Mauro, B. J. Druker posted to no-tag by acrystal on 2009-03-03 13:02:24 as
	Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. [My Copy] Nature medicine, Vol. 2, No. 5. (May 1996), pp. 561-566. by B. J. Druker, S. Tamura, E. Buchdunger, et al.S. Ohno, G. M. Segal, S. Fanning, J. Zimmermann, N. B. Lydon posted to no-tag by acrystal on 2009-03-03 13:01:54 as
	Applying the discovery of the Philadelphia chromosome. [My Copy] The Journal of clinical investigation, Vol. 117, No. 8. (August 2007), pp. 2067-2074. by D. W. Sherbenou, B. J. Druker posted to no-tag by acrystal on 2009-03-03 13:01:04 as
	Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia [My Copy] Nature Reviews Cancer, Vol. 7, No. 5., pp. 345-356. by Ellen Weisberg, Paul W. Manley, Sandra W. Cowan-Jacob, Andreas Hochhaus, James D. Griffin posted to no-tag by acrystal on 2009-03-03 13:00:23 as
	Translation of the Philadelphia chromosome into therapy for CML [My Copy] Blood, Vol. 112, No. 13. (15 December 2008), pp. 4808-4817. by Brian J. Druker posted to no-tag by acrystal on 2009-03-03 12:56:07 as along with 1 person lrust
	Cancer stem cells in solid tumours: accumulating evidence and unresolved questions [My Copy] Nature Reviews Cancer, Vol. 8, No. 10. (11 September 2008), pp. 755-768. by Jane E. Visvader, Geoffrey J. Lindeman posted to cancer cells stem by acrystal on 2008-10-22 16:28:59 as along with 8 people and 1 group singhsh ipark-kaist xingxu catcremona xtizon Zephyrus ajaymalik songpku Roswell Cancer Crosstalk
	Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. [My Copy] Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, Vol. 27, No. 3. (March 2006), pp. 279-286. by A. D. Lipworth, E. P. Hyle, N. O. Fishman, et al.I. Nachamkin, W. B. Bilker, A. M. Marr, L. A. Larosa, N. Kasbekar, E. Lautenbach posted to no-tag by acrystal on 2008-10-22 15:45:18 as
	Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases [My Copy] Cell Res, Vol. 18, No. 10. (October 0000), pp. 997-1006. by Xi Chen, Yi Ba, Lijia Ma, et al.Xing Cai, Yuan Yin, Kehui Wang, Jigang Guo, Yujing Zhang, Jiangning Chen, Xing Guo, Qibin Li, Xiaoying Li, Wenjing Wang, Yan Zhang, Jin Wang, Xueyuan Jiang, Yang Xiang, Chen Xu, Pingping Zheng, Juanbin Zhang, Ruiqiang Li, Hongjie Zhang, Xiaobin Shang, Ting Gong, Guang Ning, Jun Wang, Ke Zen, Junfeng Zhang, Chen-Yu Zhang posted to biomarker cancer mirna by acrystal on 2008-10-22 15:41:43 as along with 5 people and 1 group gdb Zephyrus jfr abizar orzenil Roswell Cancer Crosstalk
	Smad4 signalling in T cells is required for suppression of gastrointestinal cancer [My Copy] Nature, Vol. 441, No. 7096., pp. 1015-1019. by Byung-Gyu Kim, Cuiling Li, Wenhui Qiao, et al.Mizuko Mamura, Barbara Kasperczak, Miriam Anver, Lawrence Wolfraim, Suntaek Hong, Elizabeth Mushinski, Michael Potter, Seong-Jin Kim, Xin-Yuan Fu, Chuxia Deng, John J. Letterio posted to no-tag by acrystal on 2007-07-30 03:06:03 as along with 2 people laurabailey jryanstevens
	Smad4 haploinsufficiency in mouse models for intestinal cancer [My Copy] Oncogene, Vol. aop, No. current. by P. Alberici, S. Jagmohan-Changur, E. De Pater, et al.M. Van Der Valk, R. Smits, P. Hohenstein, R. Fodde posted to no-tag by acrystal on 2007-07-30 03:05:36 as
	Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest. [My Copy] posted to no-tag by acrystal on 2007-07-28 16:31:01 as
	TGFbeta signaling in growth control, cancer, and heritable disorders. [My Copy] Cell, Vol. 103, No. 2. (13 October 2000), pp. 295-309. by J. Massagué, S. W. Blain, R. S. Lo posted to cancer review smad tgfb by acrystal on 2007-07-28 16:30:02 as
	Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. [My Copy] Genes Dev, Vol. 20, No. 22. (15 November 2006), pp. 3130-3146. by N. Bardeesy, K. H. Cheng, J. H. Berger, et al.G. C. Chu, J. Pahler, P. Olson, A. F. Hezel, J. Horner, G. Y. Lauwers, D. Hanahan, R. A. DePinho posted to panin pdac smad4 tgfb by acrystal on 2007-07-28 16:28:27 as
	The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer. [My Copy] Mol Cancer Res, Vol. 4, No. 11. (November 2006), pp. 861-872. by A. Buck, M. Buchholz, M. Wagner, G. Adler, T. Gress, V. Ellenrieder posted to no-tag by acrystal on 2007-07-28 16:24:06 as
	The molecular pathogenesis of pancreatic cancer: clarifying a complex circuitry. [My Copy] Genes Dev, Vol. 20, No. 22. (15 November 2006), pp. 3049-3053. by A. K. Rustgi posted to pdac review by acrystal on 2007-07-28 16:23:14 as
	Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. [My Copy] Genes Dev, Vol. 20, No. 22. (15 November 2006), pp. 3147-3160. by H. Ijichi, A. Chytil, A. E. Gorska, et al.M. E. Aakre, Y. Fujitani, S. Fujitani, C. V. Wright, H. L. Moses posted to no-tag by acrystal on 2007-07-28 16:22:31 as
	Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. [My Copy] Cancer Cell, Vol. 11, No. 3. (March 2007), pp. 229-243. by K. Izeradjene, C. Combs, M. Best, et al.A. Gopinathan, A. Wagner, W. M. Grady, C. X. Deng, R. H. Hruban, N. V. Adsay, D. A. Tuveson, S. R. Hingorani posted to no-tag by acrystal on 2007-07-28 16:21:19 as
	TGF-beta1 down-regulates ICAM-1 expression and enhances liver metastasis of pancreatic cancer. [My Copy] Adv Med Sci, Vol. 51 (2006), pp. 60-65. by T. Sawada, K. Kimura, T. Nishihara, et al.N. Onoda, H. Teraoka, Y. Yamashita, N. Yamada, M. Yashiro, M. Ohira, K. Hirakawa posted to no-tag by acrystal on 2007-07-28 16:20:38 as
	Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness. [My Copy] Mol Pharmacol, Vol. 72, No. 1. (July 2007), pp. 152-161. by N. J. Gaspar, L. Li, A. M. Kapoun, et al.S. Medicherla, M. Reddy, G. Li, G. O'Young, D. Quon, M. Henson, D. L. Damm, G. T. Muiru, A. Murphy, L. S. Higgins, S. Chakravarty, D. H. Wong posted to no-tag by acrystal on 2007-07-28 16:19:19 as
	Quantitative proteomic analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. [My Copy] Mol Cell Proteomics (12 May 2007) by Ru Chen, Teresa A A. Brentnall, Sheng Pan, et al.Kelly Cooke, Kara White Moyes, David A A. Crispin, David R R. Goodlett, Ruedi Aebersold, Mary P P. Bronner posted to biomarker cancer chronic pancreatic pancreatitis by acrystal on 2007-06-28 19:03:16 as
	Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer. [My Copy] Cancer Epidemiol Biomarkers Prev, Vol. 16, No. 5. (May 2007), pp. 886-891. by K. F. Kuhlmann, J. W. van Till, M. A. Boermeester, et al.P. R. de Reuver, I. D. Tzvetanova, G. J. Offerhaus, F. J. Ten Kate, O. R. Busch, T. M. van Gulik, D. J. Gouma, H. C. Crawford posted to biomarker cancer pancreatic by acrystal on 2007-06-28 19:02:46 as
	Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells [My Copy] British Journal of Cancer, Vol. aop, No. current. (16 January 2007) by Y. Nakano, S. Tanno, K. Koizumi, et al.T. Nishikawa, K. Nakamura, M. Minoguchi, T. Izawa, Y. Mizukami, T. Okumura, Y. Kohgo posted to biomarker cancer gemcitabine pancreatic resistance by acrystal on 2007-06-28 18:40:27 as
	Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. [My Copy] Pancreas, Vol. 34, No. 2. (March 2007), pp. 205-214. by M. Ehmann, K. Felix, D. Hartmann, et al.M. Schnölzer, M. Nees, S. Vorderwülbecke, R. Bogumil, M. W. Büchler, H. Friess posted to biomarker ca cancer pancreatic cml by acrystal on 2007-06-28 18:34:57 as
	The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer. [My Copy] J Surg Res, Vol. 140, No. 1. (1 June 2007), pp. 31-35. by C. M. Kang, J. Y. Kim, G. H. Choi, et al.K. S. Kim, J. S. Choi, W. J. Lee, B. R. Kim posted to biomarker ca cancer pancreatic cml by acrystal on 2007-06-28 18:31:08 as
	CEACAM1, a novel serum biomarker for pancreatic cancer. [My Copy] Pancreas, Vol. 34, No. 4. (May 2007), pp. 436-443. by D. M. Simeone, B. Ji, M. Banerjee, et al.T. Arumugam, D. Li, M. A. Anderson, A. M. Bamberger, J. Greenson, R. E. Brand, V. Ramachandran, C. D. Logsdon posted to biomarker cancer pancreatic by acrystal on 2007-06-28 18:27:47 as
	Membrane topology of gamma-secretase component PEN-2. [My Copy] J Biol Chem, Vol. 278, No. 22. (30 May 2003), pp. 20117-20123. by A. S. Crystal, V. A. Morais, T. C. Pierson, et al.D. S. Pijak, D. Carlin, V. M. Lee, R. W. Doms posted to mine by acrystal on 2007-06-28 18:22:07 as
	Genetics and biology of pancreatic ductal adenocarcinoma. [My Copy] Genes Dev, Vol. 20, No. 10. (15 May 2006), pp. 1218-1249. by A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, R. A. Depinho posted to cancer pancreatic by acrystal on 2007-06-28 18:19:36 as
	Review. Molecular background of chemoresistance in pancreatic cancer. [My Copy] In Vivo, Vol. 21, No. 2. (r 2007), pp. 339-347. by A. Zalatnai, J. Molnár posted to cancer pancreatic by acrystal on 2007-06-28 18:18:26 as
	Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. [My Copy] Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], Vol. 7, No. 1. (2007), pp. 9-19. by Mansher Singh, Anirban Maitra posted to cancer pancreatic by acrystal on 2007-06-28 18:15:45 as
	Molecular genetics of pancreatic intraepithelial neoplasia. [My Copy] J Hepatobiliary Pancreat Surg, Vol. 14, No. 3. (2007), pp. 224-232. by G. Feldmann, R. Beaty, R. H. Hruban, A. Maitra posted to cancer pancreatic by acrystal on 2007-06-28 18:14:51 as
	A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114. [My Copy] J Neurochem, Vol. 86, No. 6. (September 2003), pp. 1359-1368. by A. S. Crystal, B. I. Giasson, A. Crowe, et al.M. P. Kung, Z. P. Zhuang, J. Q. Trojanowski, V. M. Lee posted to mine by acrystal on 2007-06-28 18:13:43 as
	Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation. [My Copy] Biochemistry, Vol. 43, No. 12. (30 March 2004), pp. 3555-3563. by A. S. Crystal, V. A. Morais, R. R. Fortna, et al.D. Carlin, T. C. Pierson, C. A. Wilson, V. M. Lee, R. W. Doms posted to mine by acrystal on 2007-06-28 18:12:51 as